Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis

Drug-induced Mood- and Cognition-related adverse events (MCAEs) are often only detected during the clinical trial phases of drug development, or even after marketing, thus posing a major safety concern and a challenge for both pharmaceutical companies and clinicians. To fill some gaps in the underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Andronis, Christos, Silva, João Pedro, Lekka, Eftychia, Virvilis, Vassilis, Carmo, Helena, Bampali, Konstantina, Ernst, Margot, Hu, Yang, Loryan, Irena, Richard, Jacques, Carvalho, Félix, Savić, Miroslav M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Organ Toxicity and Mechanisms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395038/
https://www.ncbi.nlm.nih.gov/pubmed/32504122
http://dx.doi.org/10.1007/s00204-020-02788-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395038/
https://www.ncbi.nlm.nih.gov/pubmed/32504122
http://dx.doi.org/10.1007/s00204-020-02788-1

Ejemplares similares